Habit SPF 41: Package Insert and Label Information
HABIT SPF 41- octisalate, avobenzone, homosalate and octocrylene spray
Bell International Laboratories, Inc
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Active Ingredient
Avobenzone 2.8%
Homosalate 9.8%
Octisalate 4.9%
Octocrylene 9.5%
Purpose
Sunscreen
Uses
Helps prevent sunurn
If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Warnings
For external use only
Do not use on damaged or broken skin
When using this producty keep out of eyes. Rinse wtih water to remove.
Stop use and ask a doctor if rash occurs
Flammable. Keep away from fire or spark.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
Directions
Apply generously 15 minutes before sun exposure
Reapply at least every 2 hours
Use a warer-resistant sunscreen if swimming or sweating
Reapply after swimming or sweating
Children under 6 monts-age: Ask a doctor
Sun Protection Meaures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
-limit time in the sun, especially from 10a.m. — 2 p.m.
-wear long-sleeved shirts, pants, hats, and sunglasses.
Other Information
Protect the product in this container from excessive heat and direct sun
Inactive Ingredients
Alcohol Denat., Bisabolol, Butyloctyl Salicylate, Capryloyl Glycerin/Sebacic Acid Copolymer, Dicaprylyl Ether, Diheptyl Succinate, Diisooctyl Succinate, Ethyl Ferulate, Isononyl Isononanoate, Lavendula Augustifolia (Lavender) Oil, Pelargonium Graveolens Flower Oil, Rosmarinus Officinalis (Rosemary) Leaf Oil
package label
| HABIT
SPF 41 facial spray | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| Labeler — Bell International Laboratories, Inc (967781555) |
Revised: 12/2020 Bell International Laboratories, Inc
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.